跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Avamax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Avamax
Approved
STANDARD
Avamax
Ranbaxy (M) Sdn. Bhd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1be19fe1452c27f8
Company
Ranbaxy (M) Sdn. Bhd
Type
Standard
Approval Details
Approval Id
1be19fe1452c27f8
Drug Approval Philippines Name
Avamax
Product Name
Avamax
Registration Number
DRP-1232-02
Brand Name
Avamax
Generic Name
Atorvastatin (as calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Ranbaxy (M) Sdn. Bhd
Importer
Ritemed Phils., Inc.
Distributor
UNILAB, INC
Issuance Date
29 January 2024
Expiry Date
02 February 2029
Pharmacologic Category
Antihypercholesterolemia
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1be19fe1452c27f8
Type
Standard
Back to Philippines FDA Approvals